someth | | Page 20

Peri- and postinterventional antithrombotic therapy in TAVI

someth5 meses desde que se envió4 meses desde que se envió02 minutos

Descarga: Peri- and postinterventional antithrombotic therapy in TAVI Archivo: tromboembolia-arterial/haemo 2016-Peri- and postinterventional antithrombotic therapy in TAVI.pdf Interventional treatment of aortic valve stenosis by transcatheter aortic valve replacement (TAVR) has become routine practice in elderly and high risk patients in recent years. Similar to other vascular interventional or surgical procedures TAVR carries thrombotic risks such…

Biomarkers for arterial and venous thrombotic disorders

someth5 meses desde que se envió4 meses desde que se envió03 minutos

Descarga: Biomarkers for arterial and venous thrombotic disorders Archivo: tromboembolia-venosa/haemo_2014-Biomarkers for arterial and venous thrombotic disorders.pdf The haemostatic system maintains the blood in a fluid state, but allows rapid clot formation at sites of vascular injury to prevent excessive bleeding. Unbalances within the haemostatic system can lead to thrombosis. Inspite of successful research our understanding…

Oral anticoagulation with edoxaban

someth5 meses desde que se envió4 meses desde que se envió02 minutos

Descarga: Oral anticoagulation with edoxaban Archivo: tromboembolia-venosa/haemo_2012-oral anticoagulation with edoxabanpdf.pdf Edoxaban (the former DU176b) an orally available direct factor Xa inhibitor has been engineered from DX-9065a, which was one of the first parenteral Xa inhibitors. Edoxaban has a time to peak plasma concentrations of 1–2 hours and a half-life of approximately 10 hours after multiple…

Biomarkers for arterial and venous thrombotic disorders

someth5 meses desde que se envió4 meses desde que se envió03 minutos

Descarga: Biomarkers for arterial and venous thrombotic disorders Archivo: tromboembolia-venosa/haemo_2014-Biomarkers for arterial and venous thrombotic disorders.pdf The haemostatic system maintains the blood in a fluid state, but allows rapid clot formation at sites of vascular injury to prevent excessive bleeding. Unbalances within the haemostatic system can lead to thrombosis. Inspite of successful research our understanding…

Assessment of Bleeding Risk of Interventional Techniques: A Best Evidence Synthesis of Practice Patterns and Perioperative Management of Anticoagulant and Antithrombotic Therapy

someth5 meses desde que se envió4 meses desde que se envió01 minutos

Descarga: Assessment of Bleeding Risk of Interventional Techniques: A Best Evidence Synthesis of Practice Patterns and Perioperative Management of Anticoagulant and Antithrombotic Therapy Archivo: userupload/pvillaca/MANEJO PERIOPERATORIO ABORDAJE.pdf Interventional pain management is a specialty that utilizes invasive procedures to diagnose and treat chronic pain. Patients undergoing these treatments may be receiving exogenous anticoagulants and antithrombotics. Even…

Platelet pathology and antiplatelet strategies

someth5 meses desde que se envió4 meses desde que se envió01 minutos

Descarga: Platelet pathology and antiplatelet strategies Archivo: eha/plaquetopatias/haemo 2016 Platelet pathology and antiplatelet strategies.pdf Blood platelets were the focus of recent issues of this Journal (1, 2). Why do these inconspicuous, small cellular fragments, derived from megakaryocytes in the bone marrow, gain so much attention both in clinical settings and basic science? Platelets contribute essentially…

Individualized antithrombotic therapy

someth5 meses desde que se envió4 meses desde que se envió05 minutos

Descarga: Individualized antithrombotic therapy Archivo: tromboembolia-venosa/haemo 2016 individualized antithrombotic therapy.pdf Clot formation in the circulation is a physiological mechanism preventing bleeding at sites of loss of vascular integrity. Clot formation may also occur intravascularly under pathological conditions, e. g. leading to myocardial infarction, stroke, and critical limb ischaemia. Clot formation involves activation of the coagulation…

Management of acquired haemophilia A

someth5 meses desde que se envió4 meses desde que se envió02 minutos

Descarga: Management of acquired haemophilia A Archivo: eha/inhibfact/haemo 2015-Management of acquired haemophilia A.pdf Acquired haemophilia A (AHA) is caused by autoantibody inhibitors of coagulation factor VIII (FVIII : C). Recent onset of bleeds and isolated prolongation of the activated partial thromboplastin time (aPTT) are characteristic features of the disorder. Reduced FVIII : C activity and…

Individualized antithrombotic therapy

someth5 meses desde que se envió4 meses desde que se envió05 minutos

Descarga: Individualized antithrombotic therapy Archivo: tromboembolia-venosa/haemo 2016 individualized antithrombotic therapy.pdf Clot formation in the circulation is a physiological mechanism preventing bleeding at sites of loss of vascular integrity. Clot formation may also occur intravascularly under pathological conditions, e. g. leading to myocardial infarction, stroke, and critical limb ischaemia. Clot formation involves activation of the coagulation…

Evolución del conocimiento sobre la sangre y su movimiento. Parte II

someth5 meses desde que se envió4 meses desde que se envió04 minutos

Descarga: Evolución del conocimiento sobre la sangre y su movimiento. Parte II Archivo: historia/Composicion sangre II.pdf Conocer de que está hecha la sangre y cuáles son los beneficios que sus componentes prestan a la vida fue una interrogante que estimuló por siglos la curiosidad de los investigadores. Cada una de las épocas del saber humano…